Bronchial Diseases: Clinical Trials

6,295 trials for Bronchial Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4105 completed, 761 unknown, 479 recruiting, 391 terminated. 1738 Not applicable, 1024 Phase 2, 828 Phase 3, 605 Phase 4, 556 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1738Completed 1065, Unknown 269, Recruiting 150, Terminated 81, Not yet recruiting 71, Withdrawn 51, Active not recruiting 37, Enrolling by invitation 9, Suspended 5
Phase 21024Completed 683, Terminated 105, Recruiting 71, Unknown 65, Withdrawn 52, Active not recruiting 33, Not yet recruiting 9, Enrolling by invitation 4, Suspended 2
Phase 3828Completed 623, Terminated 61, Unknown 46, Recruiting 43, Withdrawn 26, Active not recruiting 16, Not yet recruiting 11, Enrolling by invitation 1, Suspended 1
Phase 4605Completed 409, Unknown 73, Terminated 51, Recruiting 27, Withdrawn 21, Active not recruiting 11, Not yet recruiting 10, Enrolling by invitation 3
Phase 1556Completed 404, Terminated 50, Recruiting 29, Unknown 25, Active not recruiting 20, Withdrawn 19, Not yet recruiting 8, Suspended 1
Early Phase 138Completed 21, Terminated 4, Recruiting 3, Unknown 3, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 2

Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
linvemastat, Placebo - Asthma (Diagnosis), Pulmonary Function
Phase 2Not yet recruitingForesee Pharmaceuticals Co., Ltd.1352027-03-012026-07-20
Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
Biospecimen Collection, Mindfulness Relaxation, Survey Administration - Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm
Not applicableRecruitingCity of Hope Medical Center172027-03-012026-10-16
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
HDM sublingual Immunotherapy, Placebo - Asthma, Allergy
Phase 2WithdrawnBoston Children's Hospital2027-02-012024-11-26
Prevent Wheeze Trial
Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing
Phase 4Not yet recruitingNorwegian University of Science and Technology4862027-02-012026-10-05
Changes in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)
Budesonide/Glycopyrronium/Formoterol fumarate metered dose inhaler - Asthma, Uncontrolled Asthma
Not yet recruitingAstraZeneca2002027-01-292026-11-12
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
verducatib - Bronchiectasis
Phase 3Not yet recruitingBoehringer Ingelheim15002027-01-112026-11-12
Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies
Initial assesment interwiew, Intake Interview with the Patient - Severe Asthma
Not yet recruitingUniversity Hospital, Angers202027-01-042026-10-02
Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Metered cryospray (MCS) - COPD (Chronic Obstructive Pulmonary Disease), Chronic Bronchitis
Not applicableNot yet recruitingCSA Medical, Inc.102027-01-022026-10-05
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
Slow Release DHEA, Placebo - Asthma
Phase 2Not yet recruitingIndiana University302027-01-012026-02-27
Nebulized Ketamine for Severe Asthma Attacks in Children
Ketamine (1 mg/kg), Placebo - Asthma Acute, Exacerbation of Allergic Asthma
Phase 2Not yet recruitingSultan Qaboos University602027-01-012026-07-27
Multimodal Stewardship Programme to Improve Antibiotic Prescribing for Children With Lower Respiratory Tract Infections
PRACTICE-LRTI multimodal antimicrobial stewardship programme - Bronchitis, Acute, Community-acquired Pneumonia
Not applicableNot yet recruitingTampere University500002027-01-012026-11-03
A New ECP Protocol for the Treatment of cGVHD
Experimental ECP protocol - Chronic Graft Versus Host Disease
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS542027-01-012026-11-05
Pulmonary Rehabilitation in African Countries
Centre-based Pulmonary Rehabilitation, Community-based Pulmonary Rehabilitation - Chronic Respiratory Conditions
Not applicableNot yet recruitingUniversity of Edinburgh1502027-01-012026-11-09
Sustainable Inhaler Prescribing in Intermediate Care Units
Multidisciplinary inhaler optimization intervention - Pulmonary Disease, Chronic Obstructive (COPD), Asthma (Diagnosis)
Not applicableNot yet recruitingConsorci Sanitari de l'Alt Penedès i Garraf1102027-01-012026-11-12
The LalelaLung Study: Digital Stethoscope Clinical Evaluation
StethoMe AI-enabled digital stethoscope system, Standard IMCI assessment - Pneumonia, Tuberculosis, Pulmonary
Phase 4Not yet recruitingJohns Hopkins University3502026-12-072026-11-10
Sustained Asthma Remission and Reduced Relapse Using a Comprehensive Management Strategy (SARRE-COMS)
Comprehensive Biomarker-Guided Management Strategy, Standard of Care - Asthma (Diagnosis)
Not applicableNot yet recruitingHana Serajeddini502026-12-022026-09-25
Development and Validation of the Indian Asthma Care Bundle for Reducing Readmission and Improving Post-hospitalisation Care After Discharge From Hospital Due to an Acute Asthma Exacerbation
Indian Asthma Care Bundle (I-ACB) - Asthma Exacerbation, Asthma (Diagnosis)
Not applicableNot yet recruitingAhmedabad University2602026-12-012026-09-11
Study of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate Asthma
HXN-1013, Placebo - Health Adults, Asthma
Phase 1Not yet recruitingHelixon Biotechnology (Suzhou) Co., Ltd402026-12-012026-10-28
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)
Not yet recruitingAstraZeneca2102026-11-282026-06-04
Asthma Ctrl SMART Trial
Asthma Ctrl, Asthma Ctrl+, Control - Asthma in Children, Asthma Chronic
Not applicableNot yet recruitingChildren's Hospital Medical Center, Cincinnati3892026-11-232026-11-04

Showing 20 of 6295. Sign in to see all of them.

Narrower conditions

Asthma (4474)  ·  Bronchiolitis Obliterans Syndrome (707)  ·  Pulmonary Disease, Chronic Obstructive (669)  ·  Bronchiectasis (334)  ·  Bronchiolitis (263)  ·  Lung Diseases (226)  ·  Bronchitis, Chronic (201)  ·  Hypersensitivity (192)  ·  Bronchitis (146)  ·  Rhinitis, Allergic (125)  ·  Emphysema (116)  ·  Disease (101)  ·  Respiratory Tract Diseases (101)  ·  Obesity (96)  ·  Inflammation (95)

Broader conditions

Respiratory Tract Diseases (6194)  ·  Lung Diseases, Obstructive (5767)  ·  Lung Diseases (5720)  ·  Immune System Diseases (5265)  ·  Hypersensitivity, Immediate (4552)  ·  Respiratory Hypersensitivity (4521)  ·  Hypersensitivity (4387)  ·  Pathological Conditions, Signs and Symptoms (1616)  ·  Bronchitis (1228)  ·  Pathologic Processes (1115)  ·  Infections (885)  ·  Disease Attributes (873)  ·  Chronic Disease (793)  ·  Bronchiolitis (792)

Interventions

Budesonide (180)  ·  Fluticasone (176)  ·  Albuterol (167)  ·  montelukast (159)  ·  Formoterol Fumarate (129)  ·  Fluticasone-Salmeterol Drug Combination (89)  ·  Salmeterol Xinafoate (83)  ·  Budesonide, Formoterol Fumarate Drug Combination (82)  ·  Beclomethasone (77)  ·  Omalizumab (70)  ·  Azithromycin (52)  ·  benralizumab (50)  ·  mepolizumab (50)  ·  Saline Solution (45)  ·  Tiotropium Bromide (42)

Sponsors

AstraZeneca (349)  ·  GlaxoSmithKline (280)  ·  Novartis Pharmaceuticals (94)  ·  National Heart, Lung, and Blood Institute (NHLBI) (85)  ·  Boehringer Ingelheim (69)  ·  Organon and Co (69)  ·  Chiesi Farmaceutici S.p.A. (66)  ·  Imperial College London (52)  ·  Sanofi (49)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (48)  ·  Assistance Publique - Hôpitaux de Paris (46)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (45)  ·  Brigham and Women's Hospital (44)  ·  University of North Carolina, Chapel Hill (44)  ·  Johns Hopkins University (38)

Countries

United States (2201)  ·  United Kingdom (699)  ·  Canada (564)  ·  Germany (517)  ·  France (450)  ·  China (391)  ·  Spain (353)  ·  Poland (319)  ·  Italy (283)  ·  Netherlands (230)  ·  South Korea (219)  ·  Belgium (210)  ·  Turkey (Türkiye) (207)  ·  Australia (202)  ·  Russia (191)

Top investigators

Louis-Philippe Boulet, MD (20)  ·  Elliot Israel, MD (15)  ·  Esther Garcia, MD (12)

Results publications

PMID 36472162, PMID 27881132, PMID 37010196, PMID 39393433, PMID 31319851, PMID 29400693, PMID 35691614, PMID 33217063, PMID 38127464, PMID 26704701, PMID 30954640, PMID 32816215, PMID 33305842, PMID 22329608, PMID 24184147, PMID 28065396, PMID 29174062, PMID 29536781, PMID 32180164, PMID 33289613, PMID 34098955, PMID 35636689, PMID 10573240, PMID 14713908, PMID 20075384, PMID 20851928, PMID 21060320, PMID 24838406, PMID 24966061, PMID 26369589, PMID 26498386, PMID 26612545, PMID 28889110, PMID 30802500, PMID 30876830, PMID 31047111, PMID 31251094, PMID 31447130, PMID 31613151, PMID 31760132, PMID 31798645, PMID 32071136, PMID 32298853, PMID 33223095, PMID 33369570, PMID 33465457, PMID 33710614, PMID 35287231, PMID 36253275, PMID 36356712

NIH funding

2015 (36), 2016 (35), 2009 (29), 2023 (29), 2014 (28), 2018 (25), 2017 (23), 2019 (21), 2025 (21), 2008 (13), U10HL098115 (8), U10HL074212 (6), P01HL107202 (5), R01HL135235 (5), U10HL064287 (5)